Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (3100)	11/30/2010 11:57:51 AM
From: Jibacoa	Respond to of 3722

PATH is up 10.58% on volume > 58Ks about 1.5x its ADV bigcharts.marketwatch.com In spite of reporting larger losses in the last 3Qs and the expected loss for the Yr. around $3.07 and around $1.83 in 2011 vs. $1.05 in 2009, PATH has an ACTAY of $13.88 and Stiefel Nicolaus started covering the stock today with a "buy" rating.<g> bigcharts.marketwatch.com I haven't looked into the report last week of the company's 3rdQ results, but in spite of the analysts' good expectations, it seems prudent to wait for further developments and for the stock to be able to get off its longer term DT.<g> bigcharts.marketwatch.com Bernard